ArticleCellular oncology (Dordrecht, Netherlands)2026
TFPI2 expression predicts resistance to immunotherapy plus tyrosine kinase inhibitor and informs first-line therapy selection in metastatic renal cell carcinoma.
Jiajun Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.